You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 21, 2024

Guanabenz acetate - Generic Drug Details


✉ Email this page to a colleague

« Back to Dashboard


What are the generic sources for guanabenz acetate and what is the scope of patent protection?

Guanabenz acetate is the generic ingredient in two branded drugs marketed by Ani Pharms, Chartwell Rx, Watson Labs, and Wyeth Ayerst, and is included in five NDAs. Additional information is available in the individual branded drug profile pages.

There are six drug master file entries for guanabenz acetate.

Summary for guanabenz acetate
Recent Clinical Trials for guanabenz acetate

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Yokohama City UniversityPhase 2
Kathy MillerN/A
National Institute of Neurological Disorders and Stroke (NINDS)Phase 1

See all guanabenz acetate clinical trials

Medical Subject Heading (MeSH) Categories for guanabenz acetate

US Patents and Regulatory Information for guanabenz acetate

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Wyeth Ayerst WYTENSIN guanabenz acetate TABLET;ORAL 018587-002 Sep 7, 1982 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Wyeth Ayerst WYTENSIN guanabenz acetate TABLET;ORAL 018587-001 Sep 7, 1982 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Chartwell Rx GUANABENZ ACETATE guanabenz acetate TABLET;ORAL 074517-002 Sep 30, 1998 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Watson Labs GUANABENZ ACETATE guanabenz acetate TABLET;ORAL 074025-002 Feb 28, 1994 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Ani Pharms GUANABENZ ACETATE guanabenz acetate TABLET;ORAL 074267-001 Jun 1, 1994 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for guanabenz acetate

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Wyeth Ayerst WYTENSIN guanabenz acetate TABLET;ORAL 018587-001 Sep 7, 1982 ⤷  Sign Up ⤷  Sign Up
Wyeth Ayerst WYTENSIN guanabenz acetate TABLET;ORAL 018587-003 Sep 7, 1982 ⤷  Sign Up ⤷  Sign Up
Wyeth Ayerst WYTENSIN guanabenz acetate TABLET;ORAL 018587-002 Sep 7, 1982 ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.